Translations:Benfotiamine/9/en: Difference between revisions

From Azupedia
Jump to navigation Jump to search
VisualWikitext
FuzzyBot (talk | contribs)
15,166 edits
Importing a new version from external source
Tags: Mobile edit Mobile web edit
 
(No difference)

Latest revision as of 09:19, 3 April 2024

Information about message (contribute)
This message has no documentation. If you know where or how this message is used, you can help other translators by adding documentation to this message.
Message definition (Benfotiamine)
==Research==
Benfotiamine has been studied in laboratory models of [[diabetic retinopathy]], [[neuropathy]], and [[nephropathy]]. A 2021 review of its use for diabetic polyneuropathy described two clinical trials which showed improvements in neuropathic pain and neuropathic symptoms scores, the latter of which showed a dose-response effect. The authors concluded that it could potentially serve as an economical supplement to enhance neuropathy treatment and that more research is needed.

Research

Benfotiamine has been studied in laboratory models of diabetic retinopathy, neuropathy, and nephropathy. A 2021 review of its use for diabetic polyneuropathy described two clinical trials which showed improvements in neuropathic pain and neuropathic symptoms scores, the latter of which showed a dose-response effect. The authors concluded that it could potentially serve as an economical supplement to enhance neuropathy treatment and that more research is needed.

Retrieved from "https://wiki.tiffa.net/w/index.php?title=Translations:Benfotiamine/9/en&oldid=133218"